Literature DB >> 21280170

Liver glucokinase: An overview on the regulatory mechanisms of its activity.

María L Massa1, Juan J Gagliardino, Flavio Francini.   

Abstract

Blood glucose is the primary cellular substrate and in vivo must be tightly maintained. The liver plays a key role in glucose homeostasis increasing or decreasing glucose output and uptake during fasting and feeding. Glucokinase (GCK) is central to this process. Its activity is modulated in a coordinated manner via a complex set of mechanisms: in the postprandial period, the simultaneous rise in glucose and insulin increases GCK activity by enhanced gene expression, changes in cellular location, and interaction with regulatory proteins. Conversely, in the fasting state, the combined decrease in glucose and insulin concentrations and increase in glucagon concentrations, halt GCK activity. Herein we summarize the current knowledge regarding the regulation of hepatic GCK activity.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21280170     DOI: 10.1002/iub.411

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  34 in total

1.  Kaempferol ameliorates hyperglycemia through suppressing hepatic gluconeogenesis and enhancing hepatic insulin sensitivity in diet-induced obese mice.

Authors:  Hana Alkhalidy; Will Moore; Aihua Wang; Jing Luo; Ryan P McMillan; Yao Wang; Wei Zhen; Matthew W Hulver; Dongmin Liu
Journal:  J Nutr Biochem       Date:  2018-05-01       Impact factor: 6.048

2.  A Long Non-coding RNA, lncLGR, Regulates Hepatic Glucokinase Expression and Glycogen Storage during Fasting.

Authors:  Xiangbo Ruan; Ping Li; Andrew Cangelosi; Ling Yang; Haiming Cao
Journal:  Cell Rep       Date:  2016-02-18       Impact factor: 9.423

3.  Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.

Authors:  Young Mok Lee; Hyun Sik Jun; Chi-Jiunn Pan; Su Ru Lin; Lane H Wilson; Brian C Mansfield; Janice Y Chou
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

4.  Design and Synthesis of Acetylenyl Benzamide Derivatives as Novel Glucokinase Activators for the Treatment of T2DM.

Authors:  Kaapjoo Park; Byoung Moon Lee; Kwan Hoon Hyun; Taedong Han; Dong Hoon Lee; Hyun Ho Choi
Journal:  ACS Med Chem Lett       Date:  2015-01-14       Impact factor: 4.345

Review 5.  A fresh view of glycolysis and glucokinase regulation: history and current status.

Authors:  Sigurd Lenzen
Journal:  J Biol Chem       Date:  2014-03-17       Impact factor: 5.157

Review 6.  Control strategies in systemic metabolism.

Authors:  Jessica Ye; Ruslan Medzhitov
Journal:  Nat Metab       Date:  2019-10-07

7.  A noncanonical, GSK3-independent pathway controls postprandial hepatic glycogen deposition.

Authors:  Min Wan; Karla F Leavens; Roger W Hunter; Shlomit Koren; Alexander von Wilamowitz-Moellendorff; Mingjian Lu; Santhosh Satapati; Qingwei Chu; Kei Sakamoto; Shawn C Burgess; Morris J Birnbaum
Journal:  Cell Metab       Date:  2013-07-02       Impact factor: 27.287

8.  Gene therapy using a novel G6PC-S298C variant enhances the long-term efficacy for treating glycogen storage disease type Ia.

Authors:  Lisa Zhang; Cheol Lee; Irina Arnaoutova; Javier Anduaga; Matthew F Starost; Brian C Mansfield; Janice Y Chou
Journal:  Biochem Biophys Res Commun       Date:  2020-05-16       Impact factor: 3.575

9.  Essential amino acid transporter Lat4 (Slc43a2) is required for mouse development.

Authors:  Adriano Guetg; Luca Mariotta; Lukas Bock; Brigitte Herzog; Ralph Fingerhut; Simone M R Camargo; François Verrey
Journal:  J Physiol       Date:  2015-01-16       Impact factor: 5.182

Review 10.  Heterogeneity of glycolysis in cancers and therapeutic opportunities.

Authors:  Marc O Warmoes; Jason W Locasale
Journal:  Biochem Pharmacol       Date:  2014-08-02       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.